Tenet Healthcare (NYSE:THC – Get Free Report) is set to issue its quarterly earnings data before the market opens on Tuesday, October 29th. Analysts expect the company to announce earnings of $2.33 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
Tenet Healthcare Stock Performance
Shares of THC opened at $139.77 on Monday. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.38 and a current ratio of 1.45. The stock has a 50-day moving average of $159.85 and a two-hundred day moving average of $140.77. The stock has a market cap of $13.65 billion, a P/E ratio of 5.42, a P/E/G ratio of 0.80 and a beta of 2.14. Tenet Healthcare has a one year low of $51.04 and a one year high of $171.20.
Tenet Healthcare announced that its board has approved a share buyback program on Wednesday, July 24th that permits the company to buyback $1.50 billion in shares. This buyback authorization permits the company to buy up to 10.3% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.
Insider Activity
Wall Street Analyst Weigh In
THC has been the topic of several research reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $168.00 price target on shares of Tenet Healthcare in a report on Tuesday, October 1st. Barclays raised their target price on shares of Tenet Healthcare from $156.00 to $171.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. KeyCorp began coverage on Tenet Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $200.00 price target on the stock. Wells Fargo & Company upped their target price on Tenet Healthcare from $175.00 to $195.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 22nd. Finally, Raymond James boosted their price target on Tenet Healthcare from $130.00 to $175.00 and gave the company a “strong-buy” rating in a report on Thursday, July 25th. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $157.24.
Check Out Our Latest Research Report on THC
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- About the Markup Calculator
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Stock Sentiment Analysis: How it Works
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is a buyback in stocks? A comprehensive guide for investors
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.